for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Gossamer Bio Announces Early Encouraging Safety And Biomarker Data From Phase 1/2 Study Of Gb1275

May 29 (Reuters) - Gossamer Bio Inc:

* GOSSAMER BIO ANNOUNCES EARLY ENCOURAGING SAFETY AND BIOMARKER DATA FROM PHASE 1/2 STUDY OF GB1275 AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY 2020 VIRTUAL SCIENTIFIC PROGRAM Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up